Treprostinil
- PDF / 122,353 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 30 Downloads / 154 Views
1
Treprostinil Erythema: case report A 17-year-old boy with pulmonary arterial hypertension received treprostinil 0.6 mg/mL, 12 oral inhalations (72µg) every 6 hours via Optineb-ir. He received 1740µg in one instance by using a face mask. He developed diaphoresis, hypotension and dizziness, and erythema over the central part of his face in a mask-like distribution. Vasodilation secondary to treprostinil was suspected. The erythema gradually resolved over 48 hours. Chu DH, et al. Cutaneous reaction to inhaled treprostinil. Journal of the American Academy of Dermatology 65: e123-e124, No. 4, Oct 2011. Available from: URL: 803062107 http://dx.doi.org/10.1016/j.jaad.2011.03.026 - USA
0114-9954/10/1376-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
Reactions 5 Nov 2011 No. 1376
Data Loading...
